General Mills pulls more than 735K Pillsbury rolls from shelves over possible glass contamination
General Mills is recalling over 735,000 Pillsbury rolls due to potential glass contamination.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
General Mills has initiated a recall of nearly 736,000 Pillsbury rolls. The company is pulling the products from shelves after reports of possible glass contamination.
Coverage from CBS News, The Guardian, and Fox Business emphasizes the scale of the recall, while The Healthy and PIX11 note that the action follows an FDA report. PIX11 specifically highlights that the recalled rolls were sold in New York.
Future developments depend on further FDA reporting and the company's efforts to remove the affected products from retail locations.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 18m ago.
Quick answers
How many Pillsbury rolls are being recalled?
Reports indicate between 735,000 and 736,000 rolls are being pulled from shelves.
What is the reason for the recall?
The recall is due to possible glass contamination.
Which regulatory body reported this?
The FDA is cited as the source of the report according to coverage from The Healthy and PIX11.
Coverage (7)
- FDA Announces Recall of More Than 700,000 Pillsbury Roll Products Good Housekeeping · 3h ago
- General Mills recalls nearly 736,000 Pillsbury rolls due to possible glass contamination CBS News · 3h ago
- Pillsbury Recall on Over 735,000 Bread Rolls: FDA Report The Healthy · 3h ago
- Popular bread rolls sold in NY recalled: FDA PIX11 · 3h ago
- General Mills recalls 736,000 Pillsbury rolls over glass contamination fears The Guardian · 3h ago
- General Mills pulls more than 735K Pillsbury rolls from shelves over possible glass contamination Fox Business · 3h ago
- General Mills Issues Recall For Nearly 736,000 Pillsbury Roll Products Southern Living · 4h ago
Topics
Related trends
Kalshi Will Offer Sports-Style Betting on Drug Trial Results
Prediction platform Kalshi is launching sports-style betting markets focused on biotech clinical trials and FDA drug approvals.
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved a first-of-its-kind cholesterol pill from Merck designed to drive cholesterol levels lower than statins.
US FDA sued for allowing unauthorized vaping products
Public health groups are suing the FDA over policies that permit the sale of unauthorized flavored e-cigarettes.
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
Celcuity shares fell double digits following the FDA approval of its first drug, Revtorpyk, as investors focused on launch delays.
FDA releases 14 drug rejection letters after 3-month pause
The FDA has resumed the release of Complete Response Letters (CRLs) after a three-month disclosure freeze, issuing 14 new drug rejection notices.
MagSafe battery chargers recalled after reports of fires, burn injuries
A recall has been issued for over 1,000 MagSafe power banks following reports of overheating, fires, and burn injuries.